The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy.

Tuesday, May 9, 2006: 10:00 AM-11:45 AM

A8: HPV vaccine - Information for development of recommendations and vaccine implementation

Learning Objectives: By the end of the session, participants will understand the epidemiology of HPV and the burden of HPV disease in the US, the process for developement of vaccine recommendations and program considerations for introduction of vaccine

Moderator:Lauri Markowitz
10:00 AMIntroduction -- Lauri Markowitz
10:20 AMOverview of HPV epidemiology
Eileen F. Dunne
10:40 AMUpdate on HPV vaccine and development of vaccine recommendations
Lauri E. Markowitz
11:00 AMCost effectiveness models of HPV vaccines
Harrell W. Chesson
11:20 AMNational survey of pediatricians' knowledge, beliefs and perceived barriers to HPV vaccination
Nicole Liddon
11:40 AMCollaborative efforts in California to prepare for HPV vaccine
Heidi Bauer

The 2006 National STD Prevention Conference of CDC